AGENUS INC Operating Leases, Rent Expense
AGENUS INC (AGEN) reported Operating Leases, Rent Expense of $2.40 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-05-10
- AGENUS INC operating leases, rent expense for the quarter ending 2018-03-31 was $406.00K.
- AGENUS INC operating leases, rent expense for fiscal 2018 was $2.40M, a 7.69% decline from fiscal 2017.
- AGENUS INC operating leases, rent expense for fiscal 2017 was $2.60M, a 21.21% decline from fiscal 2016.
- AGENUS INC operating leases, rent expense for fiscal 2016 was $3.30M, a 43.48% increase from fiscal 2015.
- AGENUS INC operating leases, rent expense for fiscal 2015 was $2.30M, a 9.52% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 12 month |
|---|---|---|
| 2018-12-31 | $2.40M 10-K · filed 2019-03-18 | |
| 2018-03-31 | $406.00K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $2.60M 10-K · filed 2019-03-18 | |
| 2016-12-31 | $3.30M 10-K · filed 2019-03-18 | |
| 2015-12-31 | $2.30M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $2.10M 10-K · filed 2017-03-16 | |
| 2013-12-31 | $1.60M 10-K · filed 2016-03-15 | |
| 2012-12-31 | $1.00M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $1.70M 10-K · filed 2014-03-07 | |
| 2010-12-31 | $2.60M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |